SHPRH and central nervous system cancer: Similarly, stable SHPRH, as an E3 ligase, ubiquitinated proliferating cell nuclear antigen (PCNA), thus inhibiting glioma cell proliferation and tumorigenicity (Zhang et al. 2018).